These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 2165134)

  • 1. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2.
    McDermott MR; Brais LJ; Evelegh MJ
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1497-504. PubMed ID: 2165134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-glycoprotein B monoclonal antibody protects T cell-depleted mice against herpes simplex virus infection by inhibition of virus replication at the inoculated mucous membranes.
    Eis-Hübinger AM; Schmidt DS; Schneweis KE
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():379-85. PubMed ID: 8383173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of humoral immune responses against herpes simplex virus type 2 in the murine female genital tract.
    Milligan GN; Bernstein DI
    Virology; 1995 Jan; 206(1):234-41. PubMed ID: 7831778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
    Gill N; Rosenthal KL; Ashkar AA
    J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
    Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
    J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease.
    Dix RD; Pereira L; Baringer JR
    Infect Immun; 1981 Oct; 34(1):192-9. PubMed ID: 6271681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses to vaginal or systemic infection of BALB/c mice with herpes simplex virus type 2.
    Morahan PS; Breinig MC; McGeorge MB
    J Immunol; 1977 Dec; 119(6):2030-6. PubMed ID: 72115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection.
    Chan WL; Lukig ML; Liew FY
    J Exp Med; 1985 Oct; 162(4):1304-18. PubMed ID: 2995536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
    Gallichan WS; Rosenthal KL
    Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2.
    McDermott MR; Goldsmith CH; Rosenthal KL; Brais LJ
    J Infect Dis; 1989 Mar; 159(3):460-6. PubMed ID: 2783720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
    Gillgrass AE; Ashkar AA; Rosenthal KL; Kaushic C
    J Virol; 2003 Sep; 77(18):9845-51. PubMed ID: 12941893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination by cholera toxin conjugated to a herpes simplex virus type 2 glycoprotein D peptide.
    Drew MD; Estrada-Correa A; Underdown BJ; McDermott MR
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2357-66. PubMed ID: 1383408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity.
    Toka FN; Rouse BT
    J Leukoc Biol; 2005 Jul; 78(1):178-86. PubMed ID: 15817700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed but effective induction of mucosal memory immune responses against genital HSV-2 in the absence of secondary lymphoid organs.
    Roth KL; Bhavanam S; Jiang H; Gillgrass A; Ho K; Ferreira VH; Kaushic C
    Mucosal Immunol; 2013 Jan; 6(1):56-68. PubMed ID: 22718264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
    Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
    Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boosting of vaginal HSV-2-specific B and T cell responses by intravaginal therapeutic immunization results in diminished recurrent HSV-2 disease.
    Bourne N; Keith CA; Miller AL; Pyles RB; Cohen G; Milligan GN
    J Virol; 2023 Sep; 97(9):e0066923. PubMed ID: 37655939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G, plasma cells, and lymphocytes in the murine vagina after vaginal or parenteral immunization with attenuated herpes simplex virus type 2.
    Parr EL; Parr MB
    J Virol; 1998 Jun; 72(6):5137-45. PubMed ID: 9573285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.